Overview

Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Lovastatin, Minocycline and the combination Lovastatin/Minocycline are effective in treating behavioral symptoms in Fragile X individuals.
Phase:
Phase 2
Details
Lead Sponsor:
Université de Sherbrooke
Collaborator:
FRAXA Research Foundation
Treatments:
Dihydromevinolin
L 647318
Lovastatin
Minocycline